| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 05/15/2002 | EP1204423A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/14/2002 | US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/14/2002 | US6388065 DNA for evaluating the progression potential of cervical lesions |
| 05/14/2002 | US6388064 Human 2-19 protein homologue, z219a |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388055 Mouse CC-CKR5 receptor polypeptide |
| 05/14/2002 | US6387884 Modulate binding of leukocyte to endothelial cells; antiinflammatory agents |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387676 Human cDNAs encoding polypeptides having kinase functions |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387643 Amino acid sequence; antiinflammatory agents; antiarthritic agents; anticarcinogenic agents |
| 05/14/2002 | US6387639 Ma family polypeptides and anti-Ma antibodies |
| 05/14/2002 | US6387627 Phagemid for antibody screening |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387406 Copolymer compositions for oral delivery |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387372 Polypeptides from mycrobacterium paratuberculosis |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2104678C Protein-induced morphogenesis |
| 05/14/2002 | CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2032907C Hepatitis c assay |
| 05/10/2002 | WO2002037119A2 Method of diagnosing a transmissible spongiform encephalopathy |
| 05/10/2002 | WO2002037114A1 Agent for detecting cancer's ability to metastasize |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036804A2 Method for detecting hematopoietic stem cells |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036635A2 Monoclonal antibodies for assaying lipid transfer proteins |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036624A2 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 05/10/2002 | WO2002036615A2 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | WO2002036166A2 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
| 05/10/2002 | WO2002036165A1 Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient |
| 05/10/2002 | WO2002036164A1 Blooe vegf level-lowering agent containing il-6 antagonist as the active ingredient |
| 05/10/2002 | WO2002035981A2 Methods and compositions for the treatment of human immunodeficiency virus infection |
| 05/10/2002 | WO2002011743B1 Treatment of prostate cancer |
| 05/10/2002 | WO2002009641A3 Promyostatin peptides and methods of using same |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001090304A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001085201A3 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/10/2002 | WO2001083771A3 Human phospholipase c delta 5 |
| 05/10/2002 | WO2001083750A3 Dendritic cell co-stimulator molecules |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001046420A3 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 05/10/2002 | WO2001043779A3 Anti-hiv-1 conjugates for treatment of hiv disease |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001040466A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036467A3 Mammalian receptor proteins; related reagents and methods |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 05/10/2002 | WO2000073349A9 Dr4 antibodies and uses thereof |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | CA2428023A1 Methods and compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427659A1 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | CA2427523A1 Predicting agent for metastasis |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427004A1 Method of diagnosing a transmissible spongiform encephalopathy |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020055624 Polypeptide for use in the treatment of inflammation, graft vs host disease, sepsis, tumors and metastasis |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055488 Prevention and treatment of streptococcal and staphylococcal infection |
| 05/09/2002 | US20020055478 Monitoring 103P3E8 gene products in a biological sample from a patient who has or who is suspected of having cancer and comparing the gene expression products with that of a normal sample |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |